Millions of Australians are walking around with blood test results that sit inside the reference range but tell a story of suboptimal health. Vitamin D, iron, thyroid function, testosterone, and HDL cholesterol are the five imbalances that appear most frequently in comprehensive blood panels — and they often go unnoticed because standard screening may not catch gradual shifts. This guide breaks down each one: what the data says, what the numbers mean, and why tracking these markers over time may help you understand your health more clearly.

Why common imbalances slip through the cracks

Most blood tests in Australia are ordered reactively. You visit your GP with a specific complaint, and the tests ordered are targeted at confirming or ruling out a diagnosis. This approach works well for acute problems, but it means gradual imbalances — the kind that develop over months or years — can go undetected until they become clinically significant. The five imbalances covered in this guide share a common pattern. They develop slowly. Their early symptoms are vague — fatigue, low mood, brain fog, poor recovery — and easily attributed to stress, ageing, or a busy lifestyle. And their reference ranges are broad, meaning you can sit at the lower end of normal for years while experiencing real symptoms. Reference ranges are designed to capture the middle 95% of a healthy population. They tell you whether your result is statistically unusual, not whether it is optimal for you. A ferritin of 32 µg/L is technically within range for many laboratories, but a growing body of clinical evidence suggests it may be associated with fatigue and poor exercise tolerance. A TSH of 3.8 mIU/L is within the standard range, but some endocrinologists consider values above 2.5 mIU/L worth monitoring if symptoms are present. This is not about overriding clinical judgement or second-guessing your GP. It is about understanding that comprehensive, regular testing — with results tracked over time — gives you a richer picture of your health than any single snapshot can provide. The five imbalances below are the ones we see most frequently, and each one is measurable, understandable, and actionable.

1. Vitamin D — the most common deficiency in Australia

It seems counterintuitive that Australians would be deficient in the sunshine vitamin, but the data is clear. According to the Australian Bureau of Statistics' 2011-12 Australian Health Survey — the most recent national biomedical survey of its kind — 23% of Australian adults had a vitamin D level below 50 nmol/L. The seasonal variation was significant: 36% were deficient in winter compared to 14% in summer (ABS, 2014). Note that these figures are based on 2011-12 data; a more recent national survey may yield different prevalence estimates. People living in southern states, those who work indoors, people with darker skin, and those who cover their skin for cultural or sun-protection reasons are at particularly high risk. Vitamin D is measured as 25-hydroxyvitamin D in a blood test. In Australia, results are reported in nmol/L. The RCPA reference thresholds are: below 30 nmol/L is deficient, 30-50 nmol/L is insufficient, and above 50 nmol/L is adequate (RCPA, 2024). Some experts consider 75 nmol/L or above to be a preferable target, though this is not universally agreed upon as a clinical threshold and should be discussed with your healthcare provider. Vitamin D plays a role well beyond bone health. It is involved in immune function, muscle strength, mood regulation, and cellular processes throughout the body. Deficiency can present as fatigue, muscle weakness, bone pain, low mood, and frequent illness — but many people experience tiredness as their only noticeable symptom. Because the body stores vitamin D in fat tissue, levels can decline gradually over months without any acute change, making it easy to attribute the symptoms to other causes. What makes vitamin D deficiency particularly relevant to regular testing is its seasonality. A result taken in March may look adequate, while the same person tested in August may be well below the threshold. Annual testing — ideally at a consistent time of year — establishes your personal pattern and helps you and your healthcare provider determine whether supplementation is warranted and at what dose.

2. Iron and ferritin — the silent drain on energy

Iron deficiency is one of the most common nutritional deficiencies in Australia, and ferritin — the protein that stores iron in your body — is the single most useful marker for detecting it early. According to Pasricha et al. in the Medical Journal of Australia (2024), 22.3% of Australian women have depleted iron stores, defined as ferritin below 30 µg/L. Among pre-menopausal women aged 16-44, the prevalence rises to 34.1% (Pasricha et al., MJA, 2024). At the 30 µg/L threshold, ferritin has a 92% sensitivity and 98% specificity for iron deficiency (Pasricha et al., MJA, 2024), making it an exceptionally reliable marker. When ferritin is low, your body's iron reserves are depleted — and because iron is essential for haemoglobin production and oxygen transport, the consequences are felt throughout the body. Fatigue, weakness, breathlessness, difficulty concentrating, poor exercise tolerance, and hair thinning are common symptoms. The challenge with iron deficiency is that it develops in stages. In the earliest stage, ferritin drops but haemoglobin and other markers remain normal. You may feel vaguely tired but not enough to prompt a GP visit. By the time haemoglobin falls and frank anaemia is diagnosed, stores have been depleted for months — sometimes years. Comprehensive testing that includes ferritin catches this early stage, when dietary changes or low-dose supplementation may be sufficient to restore stores. It is also worth noting that ferritin is an acute phase reactant — it rises during inflammation, infection, and certain chronic conditions. This means a normal or elevated ferritin does not always rule out iron deficiency. A complete iron panel (serum iron, transferrin, transferrin saturation) alongside ferritin provides a more accurate picture. But as a standalone screening marker, ferritin remains the most informative starting point for assessing iron status. Common causes of low ferritin in Australia include menstrual blood loss, insufficient dietary iron intake, pregnancy, endurance exercise, and gastrointestinal conditions that impair absorption such as coeliac disease.

3. Thyroid function (TSH) — the metabolic thermostat

Your thyroid gland is a small, butterfly-shaped organ at the base of your neck that controls your metabolic rate — how fast your body converts food into energy. When it underperforms (hypothyroidism), everything slows down. Fatigue, weight gain, cold intolerance, dry skin, constipation, brain fog, and low mood are hallmark symptoms. According to RACGP clinical guidelines, hypothyroidism affects approximately 1 in 33 Australians, and an estimated 3.6% of the population has unrecognised thyroid dysfunction (RACGP, 2024). TSH (thyroid-stimulating hormone) is the primary screening marker for thyroid function. It works inversely: when your thyroid is underperforming, your pituitary gland produces more TSH to try to stimulate it. A rising TSH is often the earliest detectable sign that thyroid function is declining. The standard reference range is 0.4-4.0 mIU/L. Some endocrinologists consider values above 2.5 mIU/L worth monitoring in the presence of symptoms, though this is not a universally adopted clinical threshold — discuss borderline results with your GP. Subclinical hypothyroidism — where TSH is mildly elevated but free T4 and free T3 remain within the normal range — is far more common than overt hypothyroidism. According to the RACGP, it affects an estimated 4-8% of the general population and up to 15-18% of women over 60 (RACGP, 2024). It can cause real and measurable symptoms, particularly fatigue, weight changes, and mood disturbances, despite technically normal thyroid hormone levels. Without routine TSH testing, subclinical hypothyroidism may go undetected for years. Hashimoto's thyroiditis — an autoimmune condition where the immune system gradually attacks the thyroid gland — is the most common cause of hypothyroidism in Australia. It tends to progress slowly, with TSH rising incrementally over years. This is precisely the kind of gradual shift that annual testing is designed to detect. A TSH of 2.0 mIU/L one year, 3.2 mIU/L the next, and 4.5 mIU/L the year after tells a clear story that a single test would miss. Thyroid testing is particularly important for women, who are five to eight times more likely than men to develop thyroid conditions. Women planning pregnancy should be aware that even mild thyroid dysfunction can affect fertility and pregnancy outcomes.

Track the imbalances that matter most

Listen Health's annual membership tests over 100 biomarkers — including vitamin D, ferritin, full iron studies, thyroid function, testosterone, and a complete lipid panel — through accredited Australian pathology laboratories. Track your results year over year and catch trends early.

Start Testing Today
Developed by leading doctorsNo waiting, no referrals2,000+ locations Australia-wide

4. Testosterone — not just a male concern

Testosterone is often framed as a male hormone, but it plays important physiological roles in both men and women. In men, it is the primary androgen responsible for muscle mass, bone density, red blood cell production, libido, mood, and energy. In women, it contributes to bone health, muscle maintenance, libido, and general vitality — albeit at much lower circulating levels. Androgen deficiency affects approximately 1 in 200 Australian men overall (Healthy Male, 2024). Age-related decline is gradual — testosterone levels decrease by roughly 1% per year after age 30 (Endocrine Society of Australia, 2023). This means a man in his 50s may have testosterone levels 20-30% lower than his 30-year-old self, and the decline may go unnoticed because symptoms are vague and often attributed to ageing: reduced energy, decreased motivation, increased body fat, reduced muscle mass, lower libido, and mood changes. In Australia, total testosterone is measured in nmol/L. The generally accepted reference range for adult males is approximately 8-30 nmol/L, though this varies between laboratories and with age. Levels below 8 nmol/L combined with consistent symptoms warrant clinical investigation. The Endocrine Society of Australia recommends that testosterone should be measured on a morning fasting blood sample (ideally before 10 am), as levels peak in the early morning and decline throughout the day. For women, testosterone is measured in nmol/L as well, with a much lower reference range. Both high and low testosterone can cause symptoms in women. Elevated testosterone — seen in conditions such as polycystic ovary syndrome (PCOS) — can cause acne, excess hair growth, and irregular cycles. Low testosterone may contribute to fatigue, reduced libido, and poor bone density. What makes testosterone relevant to this list is that it rarely appears in standard GP blood panels unless specifically requested. Many men experiencing the symptoms of gradual decline assume it is simply part of getting older — and without a baseline measurement, there is no way to know whether their levels have changed significantly. Annual comprehensive testing that includes testosterone provides that baseline and tracks the trend over time.

5. HDL cholesterol — the overlooked side of your lipid panel

When most people hear cholesterol, they think about total cholesterol or LDL (the so-called bad cholesterol). But HDL cholesterol — high-density lipoprotein — plays a critical protective role that is often underappreciated. HDL helps remove excess cholesterol from your arteries and transport it back to the liver for disposal. Low HDL is independently associated with increased cardiovascular risk, even when LDL and total cholesterol are within range. The numbers in Australia warrant attention. According to NPS MedicineWise (2024), approximately 1 in 3 Australian adults has high total cholesterol. But the clinical focus on total cholesterol and LDL can mean that low HDL — an independent cardiovascular risk factor — receives less attention. Many patients who are managed with statins for elevated LDL still do not achieve adequate HDL levels, because statins primarily target LDL reduction. In Australian pathology, HDL cholesterol is measured in mmol/L. Generally, levels above 1.0 mmol/L for men and above 1.3 mmol/L for women are considered desirable. Levels below these thresholds are associated with increased cardiovascular risk regardless of other lipid values. The total cholesterol to HDL ratio is also a useful metric — a ratio below 4.5 is generally considered favourable. Low HDL is influenced by a combination of genetics, lifestyle, and metabolic factors. Smoking, physical inactivity, excess body weight (particularly visceral fat), type 2 diabetes, and a diet high in refined carbohydrates and trans fats are all associated with reduced HDL levels. Conversely, regular aerobic exercise, moderate alcohol consumption, weight loss, and diets rich in unsaturated fats (such as olive oil, nuts, and oily fish) are associated with higher HDL. The reason HDL makes this list is that it represents a modifiable risk factor that many people are unaware of. You might know your total cholesterol number from a previous test, but unless you have looked at the breakdown — and specifically at your HDL — you may be missing a key part of the picture. Tracking HDL over time alongside other lipid markers gives you and your healthcare provider a more complete cardiovascular risk assessment.

Why these five imbalances matter together

Each of the five imbalances above is clinically significant on its own. But in practice, they rarely exist in isolation. The person with low ferritin often has suboptimal vitamin D. The person with subclinical hypothyroidism may also have unfavourable lipid ratios, because thyroid function directly influences cholesterol metabolism. Low testosterone in men is associated with increased visceral fat and reduced HDL — creating a cascade that no single marker would fully reveal. This is the fundamental argument for comprehensive testing over targeted screening. When you test only the biomarker associated with your primary complaint, you get a narrow answer. When you test a broad panel — covering metabolic, hormonal, nutritional, and cardiovascular markers — you see how these systems interact. Patterns emerge that would be invisible in isolation. The other factor that unites these five imbalances is the value of trending over time. A single result tells you where you are today. Two or more results, taken at consistent intervals, tell you the direction you are heading. A declining ferritin trend, a gradually rising TSH, or an HDL that has dropped 0.3 mmol/L over two years — these are signals that prompt early investigation and intervention, long before they would trigger an alert on a single test. Annual comprehensive blood testing is not about replacing your GP or diagnosing conditions. It is about building a longitudinal record of your health that helps you and your healthcare provider make more informed decisions. The five imbalances in this guide are common, measurable, and — critically — actionable. In most cases, early identification allows for informed conversations with your healthcare provider about management options — whether that involves dietary changes, supplementation, lifestyle modification, or referral for further investigation.

Key Takeaways

Key Takeaways
  • Vitamin D deficiency affected 23% of Australian adults, rising to 36% in winter (ABS, 2011-12 Australian Health Survey) — despite Australia's sunny climate.
  • Iron deficiency (ferritin <30 µg/L) affects 22.3% of Australian women and 34.1% of pre-menopausal women aged 16-44 (Pasricha et al., MJA, 2024).
  • Subclinical hypothyroidism affects an estimated 4-8% of the general population and up to 15-18% of women over 60 (RACGP, 2024) — often without obvious symptoms.
  • Testosterone declines by approximately 1% per year after age 30 in men (ESA, 2023), but is rarely included in standard GP blood panels.
  • Low HDL cholesterol is an independent cardiovascular risk factor that is often overshadowed by the focus on LDL and total cholesterol.
  • These five imbalances develop gradually, which is why annual testing and trending results over time is more informative than one-off tests.
  • Reference ranges define what is statistically normal — not necessarily what is optimal for you. Discuss borderline results with your healthcare provider.
  • Listen Health tests over 100 biomarkers — including all five discussed in this guide — through accredited Australian pathology laboratories.

Frequently Asked Questions

AHPRA Disclaimer: This information is general in nature and should not replace individual medical advice. Always discuss your test results and health concerns with a registered healthcare practitioner.

References

  1. Australian Bureau of Statistics. Vitamin D. ABS, Australian Government, 2014 (based on 2011-12 Australian Health Survey).
  2. Royal College of Pathologists of Australasia. Vitamin D. RCPA Manual, 2024.
  3. Pasricha SR, et al. Updating the diagnosis and management of iron deficiency in the era of routine ferritin testing. Medical Journal of Australia, 2024; 221(7).
  4. Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice — Thyroid disease. RACGP, 2024.
  5. Healthy Male (Andrology Australia). Testosterone deficiency. Healthy Male, 2024.
  6. Endocrine Society of Australia. Position statement on male hypogonadism. ESA, 2023.
  7. NPS MedicineWise. Cholesterol — managing your levels. NPS MedicineWise, Australian Government, 2024.
  8. Healthdirect Australia. Iron Deficiency — Symptoms, Causes, Treatment and Prevention. Healthdirect, Australian Government, 2024.
  9. Healthdirect Australia. Hypothyroidism. Healthdirect, Australian Government, 2024.